Untargeted metabolomics HRMS data processing using regions of interest and multivariate curve resolution approaches to unveil health-to-disease transition

• Type: Article in International Scientific Journal
• Date: 2025

Authors

Luisa Barreiros (Author) FFUP; Benedita Sampaio-Maia (Author) FMDUP; Alencastre, IS (Author) Other; Tauler, R (Author) Other; Marcela A Segundo (Author) FFUP

Journal

Title: Microchemical Journal

Vol. 213

ISSN: 0026-265X

Publisher: Elsevier

Indexing

ISI Web of Knowledge - 0 Citations

Scopus - 0 Citations

Other information

Authenticus ID: P-018-SJH

DOI: 10.1016/j.microc.2025.113737

Abstract (EN): Early diagnosis has the potential to prevent or minimize the progression of diseases. The discovery of biomarkers that permit to pinpoint the health-to-disease transition is thus of crucial importance to improve diagnostic efficiency and treatment. Over the last years, untargeted metabolomic analysis of biomatrices has become a valuable tool to identify biomarkers of health status. However, it is still a recent research field with many challenges to address, namely the implementation of data treatment strategies that allow to deal efficiently with the highly complex data sets generated, without losing accuracy or relevant information. This work pursued the application of the chemometrics method Regions of Interest-Multivariate Curve Resolution (ROIMCR) to the MSbased metabolomic profiling of plasma samples aiming at the identification of chronic kidney disease (CKD) biomarkers. ROIMCR successfully resolved the plasma profiles of three groups of individuals: healthy controls, intermediate stage (pre-dialysis) and end-stage (in dialysis) CKD patients. Positive (MS1+) and negative (MS1-) data were processed simultaneously without requiring previous time alignment, resulting in time-effective analysis with increased metabolite coverage and identification. Multivariate analysis (PCA, PLS-DA, ASCA) revealed that samples were clustered according to health status and permitted to determine the most influential metabolites in differentiating groups. Metabolites identification evidenced recognized biomarkers of CKD, validating the proposed approach, and potential new indicators of disease onset and progression. A new analytical workflow involving instrumental analysis by UHPLC-HRMS and data treatment by chemometrics method ROIMCR, followed by multivariate analysis, is available for plasma metabolomic profiling. This platform can be easily adapted to other biomatrices and diseases, and applied to profile the same individual along time, fostering the development of personalized medicine.

Language: English

Type (Professor's evaluation): Scientific

No. of pages: 12